糖组学治疗市场战略、顶尖企业、增长机会、2028 年分析及预测

  • Report Code : TIPRE00029576
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 330
Buy Now

Glycomic Therapeutics Market Global Analysis & Forecast 2028

Buy Now

 

糖代谢治疗市场预计将从2021 年的 990.2146 亿美元增长到 2028 年的 2575.7879 亿美元;预计 2022 年 至 2028 年的复合年增长率为 15.8%。

报告重点介绍了推动市场增长的流行趋势和因素。糖组学专注于糖蛋白、糖脂和糖胺聚糖中发现的复合碳水化合物的结构和功能。聚糖是生物系统中大部分结构变异的原因,它们在细胞表面的表现通常被称为“糖组”。这些聚糖存在于微生物组的许多区域,包括细胞表面和蛋白质,并且可能非常复杂。微生物糖组学有望彻底改变疾病诊断、癌症检测、个性化医疗、抗菌疫苗和药物发现。作为治疗剂,聚糖整合纳米材料可用作针对病毒和细菌感染以及癌细胞的疫苗。

该报告对全球糖组学治疗市场提供了见解和深入分析,强调了各种参数,包括市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括 COVID-19 大流行对所有地区市场的影响。COVID-19 大流行对糖组学治疗市场的整体影响好坏参半;因此,市场仍在获得关注,预计未来几年将增长。卫生保健系统负担过重,向所有患者提供医疗服务成为一项挑战。此外,生物技术行业还面临着大流行的不良影响。在 COVID-19 大流行期间,医疗器械公司发现难以管理其运营。许多糖组学治疗公司在美国开展业务,大流行严重影响了几家企业。然而,在大流行限制恢复正常后,手术量恢复到正常水平。随着 COVID-19 康复率的提高,医院逐渐恢复了选择性手术。医疗治疗和疫苗开发应用对基于聚糖的药物的需求也有所增加。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

糖组学治疗市场: Therapeutics Market:

糖代谢治疗市场 Therapeutics Market
  • Glycomic Therapeutics Market
    复合年增长率(2021 - 2028 年) (2021 - 2028)
    15.8%
  • 2021 年市场规模
    990.2 亿美元
  • 2028 年市场规模
    2575.8 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 英特利赫普有限公司
  • Protalix生物治疗公司
  • BioMarin 制药公司
  • 健赞公司(赛诺菲)
  • Halozyme Therapeutics, Inc.
  • 拜耳公司
  • Alzheon 公司
  • 糖化酶
  • 葛兰素史克公司

区域概况

Glycomic Therapeutics Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Glycomic Therapeutics Market班级
  • 分离和合成
Glycomic Therapeutics Market结构
  • 糖蛋白
  • 针对唾液酸
  • 蛋白聚糖
  • 针对糖胺聚糖
  • 糖基磷脂酰肌醇
Glycomic Therapeutics Market适应症
  • 血栓形成与化学预防
  • 贫血
  • 抗粘连和抗炎
  • 白内障
  • 戈谢氏病
  • MPS-1 和 IV
  • 癌症
  • 阿尔茨海默氏病
  • A 型和 B 型流感
  • 其他的
Glycomic Therapeutics Market作用方式
  • 抑制神经氨酸酶
  • 抑制肝素酶和选择素并阻断生长因子和硫酸肝素之间的相互作用
  • 促红细胞生成素和酶替代疗法
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

基于地理位置的洞察

根据地域划分,全球糖组学治疗市场分为北美洲(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

市场洞察

 

加强糖组学治疗领域的研究和开发

聚糖极其复杂,存在于微生物组成分的许多区域,例如蛋白质和细胞表面。研究人员和参与者积极参与糖组学行业,并不断关注技术发展,以提供比传统技术更好的替代方案。以下是糖组学治疗市场中的一些研发示例:

  • 2022 年 2 月,美国国家科学基金会 (NSF) 向由弗吉尼亚理工大学和佐治亚大学共同牵头的新多所大学合作伙伴关系拨款约 2300 万美元,以加速美国的糖材料研究。该合作伙伴关系汇集了这些机构的顶尖科学家和工程师,以及布兰迪斯大学、伦斯勒理工学院和北卡罗来纳大学教堂山分校,以建立国家糖材料研究中心。
  • 2022 年 3 月,Palleon Pharmaceuticals 是一家开创了糖免疫学领域以治疗癌症和炎症疾病的公司,该公司宣布对 E-602 治疗晚期癌症患者的 1/2 期研究中的第一位患者进行给药。该研究名为 GLIMMER-01(糖免疫调节),是 Palleon 针对免疫抑制唾液酸聚糖的新型癌症免疫治疗方法的首项临床研究。
  • 2022年4月,CPTAC糖蛋白质组学研究人员开发了“Peptide-First”多属性聚糖识别方法。
  • 2022年3月,日本研究人员揭示了β-1,2-葡聚糖相关酶的精确机制,为复杂的糖代谢提供了新信息。新潟大学和东京理科大学的一组研究人员确定了一种具有糖基转移酶活性的新酶的结构和功能。该研究的结果于2022年1月19日公开,并发表在《生物化学杂志》第298卷第3期上。
  • 根据哥本哈根大学糖组学中心研究人员于 2022 年 2 月发表的一项研究,现在可以通过糖组学研究在不使用动物的情况下生产肝素。
  • 2022 年 2 月,由弗吉尼亚理工大学和佐治亚大学联合领导、专注于糖材料研究的国家研究中心 GlycoMIP 在两所大学举行了剪彩仪式,庆祝其国家用户设施盛大开业。GlycoMIP 将通过开创性的研究和独特的国家用户设施解决全国范围内糖材料合成、计算机建模、材料表征和知识共享方面的瓶颈问题,该设施将为科学界提供关键工具和服务。

糖组学领域的这些进步极大地推动了糖组学治疗市场的增长。

 

基于类别的洞察

根据类别,糖代谢治疗市场分为分离型和合成型。2021 年,合成型占据了更大的市场份额。然而,分离型预计在预测期内将实现更高的复合年增长率,达到 16.3%。 

 

基于结构的洞察

根据结构,糖组学治疗市场细分为糖蛋白、靶向唾液酸、蛋白聚糖、靶向糖胺聚糖、糖基磷脂酰肌醇 (GPI) 锚定蛋白和肝素基聚糖、靶向糖鞘脂等。糖蛋白细分市场在 2021 年占据最大市场份额。然而,靶向唾液酸细分市场预计在预测期内将实现最高复合年增长率。

 

基于指示的见解

根据适应症,糖代谢治疗市场细分为血栓形成和化学预防、贫血、抗粘连和抗炎、白内障、戈谢病、MPS-1 和 IV、癌症、阿尔茨海默病、甲型和乙型流感等。甲型和乙型流感细分市场在 2021 年占据了最大的市场份额,预计在预测期内将继续保持类似的趋势。

 

糖组学治疗市场报告范围

报告属性细节
2021 年市场规模990.2亿美元
2028 年市场规模2575.8亿美元
全球复合年增长率(2021 - 2028)15.8%
历史数据2019-2020
预测期2022-2028
涵盖的领域按类别
  • 分离和合成
按结构
  • 糖蛋白
  • 针对唾液酸
  • 蛋白聚糖
  • 针对糖胺聚糖
  • 糖基磷脂酰肌醇
按适应症
  • 血栓形成与化学预防
  • 贫血
  • 抗粘连和抗炎
  • 白内障
  • 戈谢氏病
  • MPS-1 和 IV
  • 癌症
  • 阿尔茨海默氏病
  • A 型和 B 型流感
  • 其他的
按作用方式
  • 抑制神经氨酸酶
  • 抑制肝素酶和选择素并阻断生长因子和硫酸肝素之间的相互作用
  • 促红细胞生成素和酶替代疗法
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 英特利赫普有限公司
  • Protalix生物治疗公司
  • BioMarin 制药公司
  • 健赞公司(赛诺菲)
  • Halozyme Therapeutics, Inc.
  • 拜耳公司
  • Alzheon 公司
  • 糖化酶
  • 葛兰素史克公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

基于行动的洞察模式

根据作用方式,糖代谢治疗市场细分为抑制神经氨酸酶;抑制肝素酶和选择素并阻断生长因子与硫酸肝素之间的相互作用;促红细胞生成素和酶替代疗法 (ERT);组织纤溶酶原激活剂;抑制葡萄糖神经酰胺合酶;白细胞介素 1、2 和 3;β 和 γ 干扰素;等。2021 年,促红细胞生成素和酶替代疗法 (ERT) 细分市场占据了最大的市场份额。然而,抑制神经氨酸酶细分市场预计将在预测期内实现最高的复合年增长率。

Intellihep Ltd;Protalix Biotherapeutics;BioMarin Pharmaceutical Inc.;Genzyme Corporation (Sanofi);Halozyme Therapeutics, Inc.;Bayer AG;Alzheon, Inc.;GlycoMar;GlaxoSmithKline plc.;以及 F. Hoffmann-La Roche Ltd 是糖代谢治疗市场的主要参与者。这些公司一直在实施各种有助于其发展的战略,从而推动市场取得多项发展。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the drivers and opportunities for the glycomic therapeutics market?

The growth of the market is attributed to wide application in various disorders followed by the development of new treatment processes, increasing research and development in the field of glycomic therapeutics, and expanding R&D investments and rising use of glycomics in various diseases leading to development of new treatment processes.

Which region is fastest growing?

Based on geography, the APAC region is anticipated to witness the highest CAGR in glycomic therapeutics market during the forecast period.

Which segment led the glycomic therapeutics market?

The synthetic segment under class segment held the largest market share in 2021.

Who are the key players in the glycomic therapeutics market?

The glycomic therapeutics market majorly consists of the players such as Intellihep Ltd; Protalix Biotherapeutics; BioMarin Pharmaceutical Inc.; Genzyme Corporation (Sanofi); Halozyme Therapeutics, Inc.; Bayer AG; Alzheon, Inc.; GlycoMar; GlaxoSmithKline plc.; and F. Hoffmann-La Roche Ltd.

The List of Companies - Glycomic Therapeutics Market

  1. Intellihep Ltd
  2. Protalix Biotherapeutics
  3. BioMarin Pharmaceutical Inc.
  4. Genzyme Corporation (Sanofi)  
  5. Halozyme Therapeutics, Inc.       
  6. Bayer AG            
  7. Alzheon, Inc.     
  8. GlycoMar
  9. GlaxoSmithKline plc.      
  10. F. Hoffmann-La Roche Ltd 

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..